Cargando…
Endocannabinoid Metabolism and Traumatic Brain Injury
Traumatic brain injury (TBI) represents a major cause of morbidity and disability and is a risk factor for developing neurodegenerative diseases, including Alzheimer’s disease (AD). However, no effective therapies are currently available for TBI-induced AD-like disease. Endocannabinoids are endogeno...
Autores principales: | Zhu, Dexiao, Gao, Fei, Chen, Chu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616221/ https://www.ncbi.nlm.nih.gov/pubmed/34831202 http://dx.doi.org/10.3390/cells10112979 |
Ejemplares similares
-
Endocannabinoid control of neuroinflammation in traumatic brain injury by monoacylglycerol lipase in astrocytes
por: Chen, Chu
Publicado: (2022) -
Endocannabinoids: A Promising Impact for Traumatic Brain Injury
por: Schurman, Lesley D., et al.
Publicado: (2017) -
Endocannabinoid metabolism and Alzheimer's disease
por: Chen, Chu
Publicado: (2022) -
Homeostatic regulation of brain functions by endocannabinoid signaling
por: Chen, Chu
Publicado: (2015) -
Endocannabinoids, Related Compounds and Their Metabolic Routes
por: Fezza, Filomena, et al.
Publicado: (2014)